EV Biotech is Other Materials in Netherlands that focus on growth media supplementation business. Founded in 2018. They cover business area such as developer, microbial production strain, optimal strain modification, growth medium supplementation, scale-up optimization, microbiology, genetic engineering, system biology, chemical compound, flavor, fragrance, biomaterial, agriculture, pharmaceutical market, industrial client, biochemical requirement.
2018
( 6 years old in 2024 )
Growth Media Supplementation
-
Zernikelaan 8
9747 AA Groningen
Netherlands
Private
developermicrobial production strainoptimal strain modificationgrowth medium supplementationscale-up optimizationmicrobiologygenetic engineeringsystem biologychemical compoundflavorfragrancebiomaterialagriculturepharmaceutical marketindustrial clientbiochemical requirement
* We use standard office opening hours in near EV Biotech's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
EV Biotech is Other Materials business from Netherlands that founded in 2018 (6 years old in 2024), EV Biotech business is focusing on Growth Media Supplementation.
EV Biotech headquarter office and corporate office address is located in Zernikelaan 8 9747 AA Groningen Netherlands.
EV Biotech was founded in Netherlands.
In 2024, EV Biotech is currently focus on growth media supplementation sector.
Above is snippet of Google Trends for "growth media supplementation" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with EV Biotech, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
